drugset / Trial / NCT00939978
Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart Surgery
Summary
The administration of rhEPO on the one day before cardiac surgery will be effective to decrease the bleeding due to the surgery.
Timeline
- Start
- 2009-04
- Primary completion
- 2010-06
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | rhEPO | Protein / enzyme biologic | — | — |